2024 annual financial data
Outlook Therapeutics 2024 Operating margin
Direct answer
Operating margin was -42,147.49%.
Operating income was -71,703,000 USD and net income was -75,367,000 USD.
Operating cash flow was Not available.
Get free Outlook Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 170,124 USD
- Operating income
- -71,703,000 USD
- Net income
- -75,367,000 USD
- Operating cash flow
- Not available